Latest News

See all news >
  • 20 February 2015

    MODE Diagnostics Bowel Health Test available on the High Street

    Mewburn Ellis client MODE Diagnostics Ltd have developed a DIY testing kit for bowel cancer and other disorders which is now available to purchase.  The early detection system called measure, uses sophisticated digital technology to check for low-level bleeding invisible to the human eye that may be an early sign of gastrointestinal disease, including cancer and stomach ulcers.  

    Jonathan Wills and Nick Sutcliffe have been assisting MODE with their patent portfolio and are pleased to have been involved with this potentially life-saving bowel health test.

    Click here for more information.

  • 13 February 2015

    Mewburn Ellis LLP congratulates the winners of the IBLF Awards 2015

    We congratulate the nine successful biotech start-ups and SMEs that were awarded the first ever IBLF (Industrial Biotechnology Leadership Forum) Awards. IBLF Chair Steve Bagshaw presented the awards in a ceremony at the Industrial Biotechnology Showcase 2015 event which took place on 11-12 February in London.   

    Fifteen companies pitched in a Dragons’ Den style session for the opportunity to gain access to expertise, funding and resources to help develop their businesses.

    As one of the sponsors of the IBLF Awards we are looking forward to working with the winners to help protect their valuable IP assets.

    Click here for more information.

  • 11 February 2015

    Mewburn Ellis LLP congratulates our client MerLion Pharmaceuticals

    We wish to congratulate our client MerLion Pharmaceuticals (MerLion) on achieving FDA approval of their drug  finafloxacin otic suspensionFinafloxacin is an antibiotic that has been developed to treat ear infections, in particular acute otitis externa, commonly known as “swimmer’s ear”.

    Mewburn Ellis partners Jeremy Webster, Richard Clegg and Sean Jauss have been assisting MerLion for the last 7 years with their patent portfolio, including supporting their successful licensing negotiations with a major North American partner on this particular drug.

    MerLion’s success with finafloxacin is a notable milestone in the development of Singapore’s biomedical sciences industry, being the first novel drug from a Singaporean company to achieve FDA approval.

    Click here for more information.

  • 06 February 2015

    Congratulations to EcoTechnilin UK: Winner of JEC Innovation Award for Sustainability

    Mewburn Ellis LLP congratulates our client EcoTechnilin on being awarded the JEC Europe 2015 Innovation Award in the Sustainability category. EcoTechnilin have developed the bio-sourced FibriRock composite, a lightweight, fast-curing, heat-resistant structural composite for aircraft applications, formed using flax, bio-resin and basalt.

    Click here for more information.

Our People

Our People

View all >

or search for an individual...

FAQ

FAQ

See answers to commonly asked questions

Patents > Trade Marks > Designs > General >
Focus on Innovation

Focus on Innovation

Innovation: the creation of new and exciting products, services and solutions.  A key part of every successful  business.

Find out more...